newsfilter
← Latest News
GlobeNewswire·

Synthorx to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today...